| Primary |
| Appetite Disorder |
50.0% |
| Pulmonary Embolism |
50.0% |
|
| Deep Vein Thrombosis |
20.0% |
| Hypotension |
20.0% |
| Pulmonary Embolism |
20.0% |
| Thrombocytopenia |
20.0% |
| Weight Decreased |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
68.4% |
| Endometrial Cancer |
5.3% |
| Anxiety |
3.5% |
| Gastric Cancer |
3.5% |
| Pain |
3.5% |
| Asthma |
1.8% |
| Epilepsy |
1.8% |
| Hormone Replacement Therapy |
1.8% |
| Hypersensitivity |
1.8% |
| Irritable Bowel Syndrome |
1.8% |
| Lung Neoplasm Malignant |
1.8% |
| Reflux Gastritis |
1.8% |
| Subdural Haematoma |
1.8% |
| Weight Decreased |
1.8% |
|
| Somnolence |
25.0% |
| Acute Myocardial Infarction |
12.5% |
| Breast Cancer |
12.5% |
| Hepatocellular Damage |
12.5% |
| Neoplasm Progression |
12.5% |
| Toxic Skin Eruption |
12.5% |
| Weight Decreased |
12.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.7% |
| Drug Use For Unknown Indication |
10.4% |
| Pain |
6.7% |
| Prophylaxis |
6.4% |
| Diffuse Large B-cell Lymphoma |
5.1% |
| Non-small Cell Lung Cancer |
3.4% |
| Decreased Appetite |
3.2% |
| Nausea |
2.6% |
| Abdominal Pain |
2.5% |
| Multiple Myeloma |
2.1% |
| Depression |
2.0% |
| Prostate Cancer |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Hypertension |
1.9% |
| Breast Cancer |
1.8% |
| Constipation |
1.8% |
| Dementia Alzheimer's Type |
1.7% |
| Metastases To Bone |
1.7% |
| Osteoporosis |
1.6% |
| Atrial Fibrillation |
1.5% |
|
| Weight Decreased |
17.4% |
| Thrombocytopenia |
11.0% |
| Death |
9.0% |
| Vomiting |
8.4% |
| Vision Blurred |
7.1% |
| Pneumonia |
5.2% |
| Neutropenia |
4.5% |
| Urinary Tract Infection |
3.9% |
| Hepatic Failure |
3.2% |
| Pyrexia |
3.2% |
| Small Intestinal Obstruction |
3.2% |
| Visual Impairment |
3.2% |
| Drug Ineffective |
2.6% |
| Proteinuria |
2.6% |
| Pulmonary Embolism |
2.6% |
| Rectal Haemorrhage |
2.6% |
| Renal Failure Acute |
2.6% |
| Unresponsive To Stimuli |
2.6% |
| Upper Gastrointestinal Haemorrhage |
2.6% |
| Wheezing |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
87.5% |
| Plasma Cell Myeloma |
12.5% |
|
| Cardio-respiratory Arrest |
100.0% |
|
